Metal Complexes as Antimicrobial, Antiviral and Antiparasitic Agents
DOI:
https://doi.org/10.14738/bjhr.1202.18504Keywords:
metal complexes, antimicrobial, antiviral, anti-parasiticAbstract
Metal complexes have demonstrated multifaceted utility, serving as potent antimicrobial, antiviral and antiparasitic agents due to their diverse properties and mechanisms of action against drug-resistant pathogens. Cobalt (III) complexes to copper (II) compounds have showcased remarkable efficacy against a variety of microbial adversaries. They exhibit broad-spectrum activity, targeting viruses, bacteria, fungi, and protozoa with equal fervour. Notably, cobalt (III) complexes like the CTC series have shown promise as antiviral agents, particularly in inhibiting the replication of the herpes simplex virus and other viral strains. Similarly, copper (II) complexes have displayed potent antiparasitic properties, effectively combating parasites such as Trypanosoma cruzi, the causative agent of Chagas disease. As the threat of antimicrobial resistance looms large, the exploration of metal complexes offers a ray of hope in the quest for effective treatments. This review explores the unique properties of these metal complexes and their application as antimicrobial, antiviral and antiparasitic agents. Furthermore, the review discusses the proposed mechanism of action of metal complexes as they interact with drug-resistant microbes.
References
Rizzotto, M. (2012). Metal complexes as antimicrobial agents. A search for antibacterial agents, 10, 45651
Wang, S., Zeng, X., Yang, Q., & Qiao, S. (2016). Antimicrobial peptides as potential alternatives to antibiotics in food animal industry. International journal of molecular sciences, 17(5), 603.
Li, F., Collins, J. G., & Keene, F. R. (2015). Ruthenium complexes as antimicrobial agents. Chemical Society Reviews, 44(8), 2529-2542.
Liang, X., Luan, S., Yin, Z., He, M., He, C., Yin, L., Zou, Y., Yuan, Z., Li, L., & Song, X. (2018). Recent advances in the medical use of silver complex. European Journal of Medicinal Chemistry, 157, 62-80.
Anastassopoulou, J., & Theophanides, T. (1995). The role of metal ions in biological systems and medicine. In Bioinorganic Chemistry: An Inorganic Perspective of Life (pp. 209-218). Springer.
Claudel, M., Schwarte, J. V., & Fromm, K. M. (2020). New antimicrobial strategies based on metal complexes. Chemistry, 2(4), 849-899.
Jomova, K., Makova, M., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., Rhodes, C. J., & Valko, M. (2022). Essential metals in health and disease. Chemico-biological interactions, 367, 110173.
Di Martino, P. (2022). Antimicrobial agents and microbial ecology. AIMS microbiology, 8(1), 1.
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023). Molecular mechanisms of antibiotic resistance revisited. Nature Reviews Microbiology, 21(5), 280-295. https://doi.org/10.1038/s41579-022-00820-y
Baig, M. I. R., Kadu, P., Bawane, P., Nakhate, K. T., Yele, S., Ojha, S., & Goyal, S. N. (2023). Mechanisms of emerging resistance associated with non-antibiotic antimicrobial agents: a state-of-the-art review. The Journal of Antibiotics, 76(11), 629-641.
Sharma, B., Shukla, S., Rattan, R., Fatima, M., Goel, M., Bhat, M., Dutta, S., Ranjan, R. K., & Sharma, M. (2022). Antimicrobial Agents Based on Metal Complexes: Present Situation and Future Prospects. International Journal of Biomaterials, 2022, 6819080. https://doi.org/10.1155/2022/6819080
Feng, Q. L., Wu, J., Chen, G. Q., Cui, F., Kim, T., & Kim, J. (2000). A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. Journal of biomedical materials research, 52(4), 662-668.
Guerra, W., de Andrade Azevedo, E., de Souza Monteiro, A. R., Bucciarelli-Rodriguez, M., Chartone-Souza, E., Nascimento, A. M. A., Fontes, A. P. S., Le Moyec, L., & Pereira-Maia, E. C. (2005). Synthesis, characterization, and antibacterial activity of three palladium (II) complexes of tetracyclines. Journal of Inorganic Biochemistry, 99(12), 2348-2354. https://doi.org/https://doi.org/10.1016/j.jinorgbio.2005.09.001
Rehman, S. U., Chohan, Z. H., Gulnaz, F., & Supuran, C. T. (2005). In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes. Journal of Enzyme Inhibition and Medicinal Chemistry, 20(4), 333-340.
El-Gammal, O. A., Mohamed, F. S., Rezk, G. N., & El-Bindary, A. A. (2021). Structural characterization and biological activity of a new metal complexes based of Schiff base. Journal of Molecular Liquids, 330, 115522.
Abo-Aly, M. M., Salem, A. M., Sayed, M. A., & Aziz, A. A. (2015). Spectroscopic and structural studies of the Schiff base 3-methoxy-N-salicylidene-o-amino phenol complexes with some transition metal ions and their antibacterial, antifungal activities. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 136, 993-1000.
De Castro, F., De Luca, E., Benedetti, M., & Fanizzi, F. P. (2022). Platinum compounds as potential antiviral agents. Coordination Chemistry Reviews, 451, 214276.
Henderson, D. A. (1987). Principles and lessons from the smallpox eradication programme. Bulletin of the World Health Organization, 65(4), 535.
Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., & Galdiero, M. (2011). Silver nanoparticles as potential antiviral agents. Molecules, 16(10), 8894-8918.
Domingo, E. (2010). Mechanisms of viral emergence. Veterinary research, 41(6).
Chang, E. L., Simmers, C., & Knight, D. A. (2010). Cobalt complexes as antiviral and antibacterial agents. Pharmaceuticals, 3(6), 1711-1728.
Takeuchi, T., Böttcher, A., Quezada, C. M., Meade, T. J., & Gray, H. B. (1999). Inhibition of thermolysin and human α-thrombin by cobalt (III) Schiff base complexes. Bioorganic & medicinal chemistry, 7(5), 815-819.
Schwartz, J. A., Lium, E. K., & Silverstein, S. J. (2001). Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. Journal of Virology, 75(9), 4117-4128.
Nash, T. E. (2014). Parasitic Diseases that Cause Seizures: Parasitic Diseases that Cause Seizures. Epilepsy Currents, 14(2_suppl), 29-34.
Lee, S.-M., Kim, M.-S., Hayat, F., & Shin, D. (2019). Recent advances in the discovery of novel antiprotozoal agents. Molecules, 24(21), 3886.
Utzinger, J., Becker, S. L., Knopp, S., Blum, J., Neumayr, A. L., Keiser, J., & Hatz, C. F. (2012). Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss medical weekly: official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology, 142.
Portes, M. C., Ribeiro, G. A., Sabino, G. L., De Couto, R. A. A., Vieira, L. Q., Alves, M. J. M., & Da Costa Ferreira, A. M. (2023). Antiparasitic Activity of Oxindolimine–Metal Complexes against Chagas Disease. Inorganics, 11(11), 420.
Lopez-Albizu, C., Rivero, R., Ballering, G., Freilij, H., Santini, M. S., & Bisio, M. M. C. (2023). Laboratory diagnosis of Trypanosoma cruzi infection: a narrative review [Review]. Frontiers in Parasitology, 2. https://doi.org/10.3389/fpara.2023.1138375
Guedes, P. M. d. M., Fietto, J. L. R., Lana, M. d., & Bahia, M. T. (2006). Advances in Chagas disease chemotherapy. Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Infective Agents), 5(2), 175-186.
Rajao, M. A., Furtado, C., Alves, C. L., Passos‐Silva, D. G., De Moura, M. B., Schamber‐Reis, B. L., Kunrath‐Lima, M., Zuma, A. A., Vieira‐da‐Rocha, J. P., & Garcia, J. B. F. (2014). Unveiling benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi. Environmental and molecular mutagenesis, 55(4), 309-321.
Docampo, R. (1990). Sensitivity of parasites to free radical damage by antiparasitic drugs. Chemicobiological interactions, 73(1), 1-27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nyasha Makuve, Rutendo Makuve
This work is licensed under a Creative Commons Attribution 4.0 International License.
